Obesity and the risk of primary liver cancer: A systematic review and meta-analysis
Background/Aims: In this systematic review and meta-analysis, we aimed to clarify the effect of obesity on the occurrence of and mortality from primary liver cancer.Methods: This study was conducted using a systematic literature search of MEDLINE, EMBASE, and the Cochrane Library until November 2018...
Gespeichert in:
| Veröffentlicht in: | Clinical and molecular hepatology Jg. 27; H. 1; S. 157 - 174 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
Korea (South)
Korean Association for the Study of the Liver
01.01.2021
The Korean Association for the Study of the Liver 대한간학회 |
| Schlagworte: | |
| ISSN: | 2287-2728, 2287-285X, 2287-285X |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Background/Aims: In this systematic review and meta-analysis, we aimed to clarify the effect of obesity on the occurrence of and mortality from primary liver cancer.Methods: This study was conducted using a systematic literature search of MEDLINE, EMBASE, and the Cochrane Library until November 2018 using the primary keywords “obesity,” “overweight,” “body mass index (BMI),” “body weight,” “liver,” “cancer,” “hepatocellular carcinoma,” “liver cancer,” “risk,” and “mortality.” Studies assessing the relationship between BMI and occurrence of or mortality from primary liver cancer in prospective cohorts and those reporting hazard ratios (HRs) or data that allow HR estimation were included.Results: A total of 28 prospective cohort studies with 8,135,906 subjects were included in the final analysis. These included 22 studies with 6,059,561 subjects for cancer occurrence and seven studies with 2,077,425 subjects for cancerrelated mortality. In the meta-analysis, an increase in BMI was associated with the occurrence of primary liver cancer (HR, 1.69; 95% confidence interval, 1.50–1.90, I2=56%). A BMI-dependent increase in the risk of occurrence of primary liver cancer was reported. HRs were 1.36 (95% CI, 1.02–1.81), 1.77 (95% CI, 1.56–2.01), and 3.08 (95% CI, 1.21–7.86) for BMI >25 kg/m2, >30 kg/m2, and >35 kg/m2, respectively. Furthermore, increased BMI resulted in enhanced liver cancer-related mortality (HR, 1.61; 95% CI, 1.14–2.27, I2=80%).Conclusions: High BMI increases liver cancer mortality and occurrence of primary liver cancer. Obesity is an independent risk factor for the occurrence of and mortality from primary liver cancer. |
|---|---|
| AbstractList | Background/Aims: In this systematic review and meta-analysis, we aimed to clarify the effect of obesity on the occurrence of and mortality from primary liver cancer.Methods: This study was conducted using a systematic literature search of MEDLINE, EMBASE, and the Cochrane Library until November 2018 using the primary keywords “obesity,” “overweight,” “body mass index (BMI),” “body weight,” “liver,” “cancer,” “hepatocellular carcinoma,” “liver cancer,” “risk,” and “mortality.” Studies assessing the relationship between BMI and occurrence of or mortality from primary liver cancer in prospective cohorts and those reporting hazard ratios (HRs) or data that allow HR estimation were included.Results: A total of 28 prospective cohort studies with 8,135,906 subjects were included in the final analysis. These included 22 studies with 6,059,561 subjects for cancer occurrence and seven studies with 2,077,425 subjects for cancerrelated mortality. In the meta-analysis, an increase in BMI was associated with the occurrence of primary liver cancer (HR, 1.69; 95% confidence interval, 1.50–1.90, I2=56%). A BMI-dependent increase in the risk of occurrence of primary liver cancer was reported. HRs were 1.36 (95% CI, 1.02–1.81), 1.77 (95% CI, 1.56–2.01), and 3.08 (95% CI, 1.21–7.86) for BMI >25 kg/m2, >30 kg/m2, and >35 kg/m2, respectively. Furthermore, increased BMI resulted in enhanced liver cancer-related mortality (HR, 1.61; 95% CI, 1.14–2.27, I2=80%).Conclusions: High BMI increases liver cancer mortality and occurrence of primary liver cancer. Obesity is an independent risk factor for the occurrence of and mortality from primary liver cancer. In this systematic review and meta-analysis, we aimed to clarify the effect of obesity on the occurrence of and mortality from primary liver cancer.BACKGROUND/AIMSIn this systematic review and meta-analysis, we aimed to clarify the effect of obesity on the occurrence of and mortality from primary liver cancer.This study was conducted using a systematic literature search of MEDLINE, EMBASE, and the Cochrane Library until November 2018 using the primary keywords "obesity," "overweight," "body mass index (BMI)," "body weight," "liver," "cancer," "hepatocellular carcinoma," "liver cancer," "risk," and "mortality." Studies assessing the relationship between BMI and occurrence of or mortality from primary liver cancer in prospective cohorts and those reporting hazard ratios (HRs) or data that allow HR estimation were included.METHODSThis study was conducted using a systematic literature search of MEDLINE, EMBASE, and the Cochrane Library until November 2018 using the primary keywords "obesity," "overweight," "body mass index (BMI)," "body weight," "liver," "cancer," "hepatocellular carcinoma," "liver cancer," "risk," and "mortality." Studies assessing the relationship between BMI and occurrence of or mortality from primary liver cancer in prospective cohorts and those reporting hazard ratios (HRs) or data that allow HR estimation were included.A total of 28 prospective cohort studies with 8,135,906 subjects were included in the final analysis. These included 22 studies with 6,059,561 subjects for cancer occurrence and seven studies with 2,077,425 subjects for cancerrelated mortality. In the meta-analysis, an increase in BMI was associated with the occurrence of primary liver cancer (HR, 1.69; 95% confidence interval, 1.50-1.90, I2=56%). A BMI-dependent increase in the risk of occurrence of primary liver cancer was reported. HRs were 1.36 (95% CI, 1.02-1.81), 1.77 (95% CI, 1.56-2.01), and 3.08 (95% CI, 1.21-7.86) for BMI >25 kg/m2, >30 kg/m2, and >35 kg/m2, respectively. Furthermore, increased BMI resulted in enhanced liver cancer-related mortality (HR, 1.61; 95% CI, 1.14-2.27, I2=80%).RESULTSA total of 28 prospective cohort studies with 8,135,906 subjects were included in the final analysis. These included 22 studies with 6,059,561 subjects for cancer occurrence and seven studies with 2,077,425 subjects for cancerrelated mortality. In the meta-analysis, an increase in BMI was associated with the occurrence of primary liver cancer (HR, 1.69; 95% confidence interval, 1.50-1.90, I2=56%). A BMI-dependent increase in the risk of occurrence of primary liver cancer was reported. HRs were 1.36 (95% CI, 1.02-1.81), 1.77 (95% CI, 1.56-2.01), and 3.08 (95% CI, 1.21-7.86) for BMI >25 kg/m2, >30 kg/m2, and >35 kg/m2, respectively. Furthermore, increased BMI resulted in enhanced liver cancer-related mortality (HR, 1.61; 95% CI, 1.14-2.27, I2=80%).High BMI increases liver cancer mortality and occurrence of primary liver cancer. Obesity is an independent risk factor for the occurrence of and mortality from primary liver cancer.CONCLUSIONHigh BMI increases liver cancer mortality and occurrence of primary liver cancer. Obesity is an independent risk factor for the occurrence of and mortality from primary liver cancer. Background/Aims In this systematic review and meta-analysis, we aimed to clarify the effect of obesity on the occurrence of and mortality from primary liver cancer. Methods This study was conducted using a systematic literature search of MEDLINE, EMBASE, and the Cochrane Library until November 2018 using the primary keywords “obesity,” “overweight,” “body mass index (BMI),” “body weight,” “liver,” “cancer,” “hepatocellular carcinoma,” “liver cancer,” “risk,” and “mortality.” Studies assessing the relationship between BMI and occurrence of or mortality from primary liver cancer in prospective cohorts and those reporting hazard ratios (HRs) or data that allow HR estimation were included. Results A total of 28 prospective cohort studies with 8,135,906 subjects were included in the final analysis. These included 22 studies with 6,059,561 subjects for cancer occurrence and seven studies with 2,077,425 subjects for cancer-related mortality. In the meta-analysis, an increase in BMI was associated with the occurrence of primary liver cancer (HR, 1.69; 95% confidence interval, 1.50–1.90, I2=56%). A BMI-dependent increase in the risk of occurrence of primary liver cancer was reported. HRs were 1.36 (95% CI, 1.02–1.81), 1.77 (95% CI, 1.56–2.01), and 3.08 (95% CI, 1.21–7.86) for BMI >25 kg/m2, >30 kg/m2, and >35 kg/m2, respectively. Furthermore, increased BMI resulted in enhanced liver cancer-related mortality (HR, 1.61; 95% CI, 1.14–2.27, I2=80%). Conclusions High BMI increases liver cancer mortality and occurrence of primary liver cancer. Obesity is an independent risk factor for the occurrence of and mortality from primary liver cancer. Background/AimsIn this systematic review and meta-analysis, we aimed to clarify the effect of obesity on the occurrence of and mortality from primary liver cancer.MethodsThis study was conducted using a systematic literature search of MEDLINE, EMBASE, and the Cochrane Library until November 2018 using the primary keywords “obesity,” “overweight,” “body mass index (BMI),” “body weight,” “liver,” “cancer,” “hepatocellular carcinoma,” “liver cancer,” “risk,” and “mortality.” Studies assessing the relationship between BMI and occurrence of or mortality from primary liver cancer in prospective cohorts and those reporting hazard ratios (HRs) or data that allow HR estimation were included.ResultsA total of 28 prospective cohort studies with 8,135,906 subjects were included in the final analysis. These included 22 studies with 6,059,561 subjects for cancer occurrence and seven studies with 2,077,425 subjects for cancer-related mortality. In the meta-analysis, an increase in BMI was associated with the occurrence of primary liver cancer (HR, 1.69; 95% confidence interval, 1.50–1.90, I2=56%). A BMI-dependent increase in the risk of occurrence of primary liver cancer was reported. HRs were 1.36 (95% CI, 1.02–1.81), 1.77 (95% CI, 1.56–2.01), and 3.08 (95% CI, 1.21–7.86) for BMI >25 kg/m2, >30 kg/m2, and >35 kg/m2, respectively. Furthermore, increased BMI resulted in enhanced liver cancer-related mortality (HR, 1.61; 95% CI, 1.14–2.27, I2=80%).ConclusionsHigh BMI increases liver cancer mortality and occurrence of primary liver cancer. Obesity is an independent risk factor for the occurrence of and mortality from primary liver cancer. In this systematic review and meta-analysis, we aimed to clarify the effect of obesity on the occurrence of and mortality from primary liver cancer. This study was conducted using a systematic literature search of MEDLINE, EMBASE, and the Cochrane Library until November 2018 using the primary keywords "obesity," "overweight," "body mass index (BMI)," "body weight," "liver," "cancer," "hepatocellular carcinoma," "liver cancer," "risk," and "mortality." Studies assessing the relationship between BMI and occurrence of or mortality from primary liver cancer in prospective cohorts and those reporting hazard ratios (HRs) or data that allow HR estimation were included. A total of 28 prospective cohort studies with 8,135,906 subjects were included in the final analysis. These included 22 studies with 6,059,561 subjects for cancer occurrence and seven studies with 2,077,425 subjects for cancerrelated mortality. In the meta-analysis, an increase in BMI was associated with the occurrence of primary liver cancer (HR, 1.69; 95% confidence interval, 1.50-1.90, I2=56%). A BMI-dependent increase in the risk of occurrence of primary liver cancer was reported. HRs were 1.36 (95% CI, 1.02-1.81), 1.77 (95% CI, 1.56-2.01), and 3.08 (95% CI, 1.21-7.86) for BMI >25 kg/m2, >30 kg/m2, and >35 kg/m2, respectively. Furthermore, increased BMI resulted in enhanced liver cancer-related mortality (HR, 1.61; 95% CI, 1.14-2.27, I2=80%). High BMI increases liver cancer mortality and occurrence of primary liver cancer. Obesity is an independent risk factor for the occurrence of and mortality from primary liver cancer. Background/Aims: In this systematic review and meta-analysis, we aimed to clarify the effect of obesity on the occurrence of and mortality from primary liver cancer. Methods: This study was conducted using a systematic literature search of MEDLINE, EMBASE, and the Cochrane Library until November 2018 using the primary keywords “obesity,” “overweight,” “body mass index (BMI),” “body weight,” “liver,” “cancer,” “hepatocellular carcinoma,” “liver cancer,” “risk,” and “mortality.” Studies assessing the relationship between BMI and occurrence of or mortality from primary liver cancer in prospective cohorts and those reporting hazard ratios (HRs) or data that allow HR estimation were included. Results: A total of 28 prospective cohort studies with 8,135,906 subjects were included in the final analysis. These included 22 studies with 6,059,561 subjects for cancer occurrence and seven studies with 2,077,425 subjects for cancerrelated mortality. In the meta-analysis, an increase in BMI was associated with the occurrence of primary liver cancer (HR, 1.69; 95% confidence interval, 1.50–1.90, I2=56%). A BMI-dependent increase in the risk of occurrence of primary liver cancer was reported. HRs were 1.36 (95% CI, 1.02–1.81), 1.77 (95% CI, 1.56–2.01), and 3.08 (95% CI, 1.21–7.86) for BMI >25 kg/m2, >30 kg/m2, and >35 kg/m2, respectively. Furthermore, increased BMI resulted in enhanced liver cancer-related mortality (HR, 1.61; 95% CI, 1.14–2.27, I2=80%). Conclusions: High BMI increases liver cancer mortality and occurrence of primary liver cancer. Obesity is an independent risk factor for the occurrence of and mortality from primary liver cancer. KCI Citation Count: 1 |
| Author | Yoon, Seung Kew Lim, Jin Hong Sohn, Won Lee, Min Woo Park, Chan Hyuk Lee, Hyun Woong Lee, Sangheun |
| Author_xml | – sequence: 1 givenname: Won surname: Sohn fullname: Sohn, Won – sequence: 2 givenname: Hyun Woong surname: Lee fullname: Lee, Hyun Woong – sequence: 3 givenname: Sangheun surname: Lee fullname: Lee, Sangheun – sequence: 4 givenname: Jin Hong surname: Lim fullname: Lim, Jin Hong – sequence: 5 givenname: Min Woo surname: Lee fullname: Lee, Min Woo – sequence: 6 givenname: Chan Hyuk surname: Park fullname: Park, Chan Hyuk – sequence: 7 givenname: Seung Kew surname: Yoon fullname: Yoon, Seung Kew |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33238333$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002663116$$DAccess content in National Research Foundation of Korea (NRF) |
| BookMark | eNp1kk1rGzEQhpeS0qRpjr0WQS_tYV19rbTbQ8GEfhgCgTaF3oSkHcWyd1eptHbxv6_WdkITqA4aIT3z8o5mXhYnQxigKF4TPGOswh9sv5xRTPEMEymeFWeU1rKkdfXr5P4saX1aXKS0wnlJTKuGvShOGaOsZoydFT-uDSQ_7pAeWjQuAUWf1ig4dBd9r-MOdX4LEVk9WIgf0RylXRqh16O3KMLWw599Zg-jLvWgu13y6VXx3OkuwcUxnhc_v3y-ufxWXl1_XVzOr0pbETKWUjeWQlu5GlpuiHXcNJxYTYyjUlrGudTcEikdFVRwLYhrJHBhGipMBY6dF-8PukN0am29Ctrv421Q66jm328WqhEsF15ndnFg26BX6ljcPmF_EeKt0jEX1YGyVlgtJDXMYo5bMC0wUnODTetcXeOs9emgdbcxPbQWhjHq7pHo45fBL7OnrZL11CySBd4dBWL4vYE0qt4nC12nBwibpCgXXGDJGp7Rt0_QVdjE_NFJMUKrKm94cvTmX0cPVu77nIHyANgYUorgHhCC1TRKKo-SmtypaZQyz57w1o-56WEqyHf_yfoLt4HL-Q |
| CitedBy_id | crossref_primary_10_1155_2022_3851604 crossref_primary_10_1016_j_acra_2023_05_022 crossref_primary_10_32604_or_2024_050903 crossref_primary_10_1007_s00011_023_01832_x crossref_primary_10_1038_s41598_021_89628_z crossref_primary_10_3389_fonc_2024_1489261 crossref_primary_10_3389_fendo_2023_1121303 crossref_primary_10_1002_ijc_34935 crossref_primary_10_1177_02601060241303630 crossref_primary_10_3390_genes15101242 crossref_primary_10_3390_ijerph21060757 crossref_primary_10_1186_s41256_025_00416_y crossref_primary_10_3389_fnut_2023_1102722 crossref_primary_10_1016_j_semcancer_2025_07_008 crossref_primary_10_1016_j_ijbiomac_2025_145679 crossref_primary_10_1016_j_jncc_2025_04_005 crossref_primary_10_3350_cmh_2021_0308 crossref_primary_10_1042_BCJ20210134 crossref_primary_10_3748_wjg_v30_i21_2777 crossref_primary_10_1016_j_soard_2024_04_019 crossref_primary_10_1097_MOU_0000000000001041 crossref_primary_10_14309_ajg_0000000000001497 crossref_primary_10_1080_14737140_2023_2203387 crossref_primary_10_3350_cmh_2022_0316 crossref_primary_10_1038_s41598_024_77658_2 crossref_primary_10_1016_j_semcancer_2025_03_007 crossref_primary_10_1038_s41575_022_00726_3 crossref_primary_10_3389_fimmu_2024_1474770 crossref_primary_10_1016_j_clinre_2024_102352 crossref_primary_10_4240_wjgs_v15_i9_1995 crossref_primary_10_1016_j_canep_2023_102468 crossref_primary_10_3390_ijms232315002 crossref_primary_10_1017_S1368980023002574 crossref_primary_10_1001_jamanetworkopen_2025_2208 crossref_primary_10_3389_fnut_2023_1286792 crossref_primary_10_1016_j_gene_2024_148320 crossref_primary_10_3390_diabetology6080079 crossref_primary_10_3390_cancers14010103 crossref_primary_10_3390_cancers14205002 crossref_primary_10_1111_eci_13936 crossref_primary_10_1186_s12885_022_09939_w crossref_primary_10_14309_ajg_0000000000001908 crossref_primary_10_3389_fpubh_2025_1590559 crossref_primary_10_3389_fendo_2023_1331739 crossref_primary_10_1055_a_2289_2298 crossref_primary_10_1002_ueg2_12334 crossref_primary_10_51847_4baf1ijyBZ crossref_primary_10_1080_09540105_2025_2490003 crossref_primary_10_3350_cmh_2020_0302 crossref_primary_10_1097_MD_0000000000039167 crossref_primary_10_1038_s41598_023_34263_z crossref_primary_10_3390_ijms25020919 crossref_primary_10_1016_j_semcancer_2025_06_006 crossref_primary_10_1111_dom_16325 crossref_primary_10_20892_j_issn_2095_3941_2022_0231 crossref_primary_10_1080_01635581_2023_2180824 crossref_primary_10_1186_s12876_025_03611_w crossref_primary_10_1159_000531397 crossref_primary_10_1016_j_ejca_2023_03_005 crossref_primary_10_1016_j_jbi_2022_103986 crossref_primary_10_1002_ijc_33920 crossref_primary_10_1097_QAD_0000000000003904 crossref_primary_10_3390_ijms221810027 crossref_primary_10_1016_j_canep_2023_102436 crossref_primary_10_1016_j_imu_2023_101187 crossref_primary_10_1007_s10555_022_10054_2 crossref_primary_10_1111_iwj_14689 crossref_primary_10_1155_2022_2756459 crossref_primary_10_1002_cnr2_1821 crossref_primary_10_1038_s41598_024_52421_9 crossref_primary_10_1038_s41598_025_86317_z crossref_primary_10_3390_cancers16112115 crossref_primary_10_1016_j_canlet_2022_215814 crossref_primary_10_3350_cmh_2022_0401 crossref_primary_10_1016_j_clinre_2022_101889 crossref_primary_10_3389_fonc_2025_1557233 crossref_primary_10_1007_s12072_024_10763_6 crossref_primary_10_1371_journal_pone_0304574 crossref_primary_10_1186_s12957_023_03275_4 crossref_primary_10_7189_jogh_14_04067 crossref_primary_10_3390_nu16203505 crossref_primary_10_1002_ijc_34751 crossref_primary_10_1016_j_nut_2023_112097 crossref_primary_10_1186_s13578_024_01248_y crossref_primary_10_3389_fendo_2025_1562854 crossref_primary_10_3390_diagnostics13010003 crossref_primary_10_32604_biocell_2024_050396 crossref_primary_10_1016_j_heliyon_2023_e14460 crossref_primary_10_3390_nu16152506 crossref_primary_10_1016_j_jfma_2023_05_029 crossref_primary_10_1007_s10552_023_01797_6 crossref_primary_10_1016_j_jhep_2021_09_007 crossref_primary_10_1016_j_puhe_2025_105893 crossref_primary_10_1016_j_ejrad_2023_111025 crossref_primary_10_1038_s41598_024_59211_3 crossref_primary_10_1289_EHP14574 crossref_primary_10_4254_wjh_v16_i3_393 crossref_primary_10_1097_HC9_0000000000000536 crossref_primary_10_1016_j_semcancer_2023_06_002 crossref_primary_10_3390_cancers16030521 crossref_primary_10_1002_oby_23913 |
| Cites_doi | 10.1038/nature12347 10.1016/j.cgh.2008.02.012 10.1016/j.cgh.2016.10.012 10.1016/j.cgh.2006.05.013 10.1002/ijc.25585 10.1038/nrdp.2016.18 10.1111/jvh.13029 10.1097/MD.0000000000004876 10.1038/sj.ijo.0803020 10.1111/jgh.14115 10.1136/bmj.315.7109.629 10.1038/srep45846 10.1093/carcin/bgr058 10.1371/journal.pone.0044522 10.1002/ijc.26338 10.1007/s10552-008-9287-6 10.1038/nrc2536 10.1053/jhep.2002.33324 10.1146/annurev-nutr-071811-150713 10.1038/sj.bjc.6602819 10.1016/j.cld.2015.01.001 10.1002/ijc.23719 10.1002/ijc.30187 10.1136/bmj.327.7414.557 10.1136/gutjnl-2016-313622 10.3810/pgm.2009.11.2074 10.1053/j.gastro.2008.03.073 10.1371/journal.pone.0112558 10.2188/jea.JE20120199 10.1007/s10654-014-9934-z 10.1002/ijc.20529 10.1158/0008-5472.CAN-16-0787 10.1016/j.cgh.2015.09.015 10.1002/ijc.30737 10.1053/j.gastro.2012.10.005 10.1016/j.jclinepi.2009.06.006 10.1007/s40273-014-0243-x 10.1182/blood-2011-06-362830 10.1158/1055-9965.EPI-08-1131 10.1146/annurev-med-051613-012328 10.1016/j.ejca.2012.02.063 10.1093/aje/kws252 10.1016/j.puhe.2008.04.003 10.1016/j.kjms.2012.12.006 10.1158/1055-9965.EPI-15-0415 10.1634/theoncologist.2012-0066 10.1016/S0140-6736(08)60269-X 10.1002/cncr.31406 10.1038/ijo.2010.20 10.1038/sj.bjc.6603932 10.1056/NEJMoa021423 10.1016/0197-2456(86)90046-2 10.1002/ijc.30818 10.1016/j.cell.2009.12.052 10.1016/0140-6736(91)90201-Y 10.1007/s10654-010-9491-z |
| ContentType | Journal Article |
| Copyright | 2021. This work is published under http://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Copyright © 2021 by The Korean Association for the Study of the Liver 2021 |
| Copyright_xml | – notice: 2021. This work is published under http://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Copyright © 2021 by The Korean Association for the Study of the Liver 2021 |
| DBID | AAYXX CITATION NPM 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 5PM DOA ACYCR |
| DOI | 10.3350/cmh.2020.0176 |
| DatabaseName | CrossRef PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials AUTh Library subscriptions: ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) Open Access: DOAJ - Directory of Open Access Journals Korean Citation Index |
| DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest One Health & Nursing ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete ProQuest Health & Medical Research Collection Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | CrossRef MEDLINE - Academic Publicly Available Content Database PubMed |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2287-285X |
| EndPage | 174 |
| ExternalDocumentID | oai_kci_go_kr_ARTI_9630008 oai_doaj_org_article_cc6ca672b3c040debde3184b0bdff880 PMC7820201 33238333 10_3350_cmh_2020_0176 |
| Genre | Journal Article Evidence Based Healthcare |
| GeographicLocations | United States--US |
| GeographicLocations_xml | – name: United States--US |
| GroupedDBID | 5-W 7X7 8FI 8FJ 8JR 8XY 9ZL AAYXX ABUWG ACYCR ADBBV AFFHD AFKRA ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV BENPR CCPQU CITATION DIK EBD EF. EMOBN FYUFA GROUPED_DOAJ HMCUK HYE KQ8 M48 PGMZT PHGZM PHGZT PIMPY RNS RPM SV3 UKHRP ADRAZ IPNFZ M~E NPM OK1 RIG 3V. 7XB 8FK AZQEC DWQXO K9. PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 PUEGO 5PM |
| ID | FETCH-LOGICAL-c511t-7a9c2ed5f8ed4b1cf4b941ca1bf277c3447a4c177f26264a61f97e46b926b5ef3 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 121 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000605666500019&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2287-2728 2287-285X |
| IngestDate | Sun Mar 09 07:55:02 EDT 2025 Tue Oct 14 19:07:27 EDT 2025 Tue Nov 04 02:02:24 EST 2025 Thu Oct 02 10:38:19 EDT 2025 Tue Oct 07 07:35:12 EDT 2025 Thu Jan 02 22:57:13 EST 2025 Sat Nov 29 06:37:40 EST 2025 Tue Nov 18 21:05:38 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Liver cancer Obesity Risk Carcinoma, Hepatocellular Mortality |
| Language | English |
| License | This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c511t-7a9c2ed5f8ed4b1cf4b941ca1bf277c3447a4c177f26264a61f97e46b926b5ef3 |
| Notes | SourceType-Scholarly Journals-1 content type line 14 ObjectType-Evidence Based Healthcare-1 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 These authors contributed equally to this work. Editor: Naoshi Nishida, Kindai University, Japan |
| ORCID | 0000-0002-4476-4868 |
| OpenAccessLink | https://doaj.org/article/cc6ca672b3c040debde3184b0bdff880 |
| PMID | 33238333 |
| PQID | 3125531200 |
| PQPubID | 7084873 |
| PageCount | 18 |
| ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_9630008 doaj_primary_oai_doaj_org_article_cc6ca672b3c040debde3184b0bdff880 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7820201 proquest_miscellaneous_2464607394 proquest_journals_3125531200 pubmed_primary_33238333 crossref_primary_10_3350_cmh_2020_0176 crossref_citationtrail_10_3350_cmh_2020_0176 |
| PublicationCentury | 2000 |
| PublicationDate | 2021-01-01 |
| PublicationDateYYYYMMDD | 2021-01-01 |
| PublicationDate_xml | – month: 01 year: 2021 text: 2021-01-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Korea (South) |
| PublicationPlace_xml | – name: Korea (South) – name: Seoul |
| PublicationTitle | Clinical and molecular hepatology |
| PublicationTitleAlternate | Clin Mol Hepatol |
| PublicationYear | 2021 |
| Publisher | Korean Association for the Study of the Liver The Korean Association for the Study of the Liver 대한간학회 |
| Publisher_xml | – name: Korean Association for the Study of the Liver – name: The Korean Association for the Study of the Liver – name: 대한간학회 |
| References | ref13 ref57 ref12 ref56 ref15 ref59 ref14 ref53 (ref58) 2004 ref11 ref55 ref10 ref54 ref17 ref16 ref19 ref18 ref51 ref50 ref46 ref45 ref48 ref47 ref42 ref41 ref44 ref43 ref49 ref8 ref7 ref9 ref4 ref3 ref6 ref5 ref40 ref35 ref34 ref37 ref36 ref31 ref30 ref33 ref32 ref2 ref1 ref39 ref38 Higgins (ref22) ref24 ref23 ref26 ref25 ref20 ref21 ref28 ref27 ref29 (ref52) 2016 33317238 - Clin Mol Hepatol. 2021 Jan;27(1):87-90 |
| References_xml | – ident: ref56 doi: 10.1038/nature12347 – ident: ref9 doi: 10.1016/j.cgh.2008.02.012 – ident: ref45 doi: 10.1016/j.cgh.2016.10.012 – ident: ref28 doi: 10.1016/j.cgh.2006.05.013 – ident: ref35 doi: 10.1002/ijc.25585 – ident: ref7 doi: 10.1038/nrdp.2016.18 – ident: ref48 doi: 10.1111/jvh.13029 – ident: ref59 doi: 10.1097/MD.0000000000004876 – start-page: 157 volume-title: Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies year: 2004 ident: ref58 – ident: ref25 doi: 10.1038/sj.ijo.0803020 – ident: ref50 doi: 10.1111/jgh.14115 – ident: ref20 doi: 10.1136/bmj.315.7109.629 – ident: ref6 doi: 10.1038/srep45846 – ident: ref34 doi: 10.1093/carcin/bgr058 – volume-title: Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 ident: ref22 – ident: ref12 doi: 10.1371/journal.pone.0044522 – ident: ref36 doi: 10.1002/ijc.26338 – ident: ref31 doi: 10.1007/s10552-008-9287-6 – ident: ref55 doi: 10.1038/nrc2536 – ident: ref8 doi: 10.1053/jhep.2002.33324 – ident: ref5 doi: 10.1146/annurev-nutr-071811-150713 – ident: ref27 doi: 10.1038/sj.bjc.6602819 – ident: ref57 doi: 10.1016/j.cld.2015.01.001 – ident: ref29 doi: 10.1002/ijc.23719 – ident: ref43 doi: 10.1002/ijc.30187 – ident: ref19 doi: 10.1136/bmj.327.7414.557 – year: 2016 ident: ref52 – ident: ref49 doi: 10.1136/gutjnl-2016-313622 – ident: ref2 doi: 10.3810/pgm.2009.11.2074 – ident: ref10 doi: 10.1053/j.gastro.2008.03.073 – ident: ref17 doi: 10.1371/journal.pone.0112558 – ident: ref38 doi: 10.2188/jea.JE20120199 – ident: ref40 doi: 10.1007/s10654-014-9934-z – ident: ref26 doi: 10.1002/ijc.20529 – ident: ref42 doi: 10.1158/0008-5472.CAN-16-0787 – ident: ref44 doi: 10.1016/j.cgh.2015.09.015 – ident: ref47 doi: 10.1002/ijc.30737 – ident: ref16 doi: 10.1053/j.gastro.2012.10.005 – ident: ref23 doi: 10.1016/j.jclinepi.2009.06.006 – ident: ref1 doi: 10.1007/s40273-014-0243-x – ident: ref15 doi: 10.1182/blood-2011-06-362830 – ident: ref32 doi: 10.1158/1055-9965.EPI-08-1131 – ident: ref4 doi: 10.1146/annurev-med-051613-012328 – ident: ref11 doi: 10.1016/j.ejca.2012.02.063 – ident: ref39 doi: 10.1093/aje/kws252 – ident: ref30 doi: 10.1016/j.puhe.2008.04.003 – ident: ref37 doi: 10.1016/j.kjms.2012.12.006 – ident: ref41 doi: 10.1158/1055-9965.EPI-15-0415 – ident: ref13 doi: 10.1634/theoncologist.2012-0066 – ident: ref3 doi: 10.1016/S0140-6736(08)60269-X – ident: ref51 doi: 10.1002/cncr.31406 – ident: ref33 doi: 10.1038/ijo.2010.20 – ident: ref54 doi: 10.1038/sj.bjc.6603932 – ident: ref24 doi: 10.1056/NEJMoa021423 – ident: ref18 doi: 10.1016/0197-2456(86)90046-2 – ident: ref46 doi: 10.1002/ijc.30818 – ident: ref53 doi: 10.1016/j.cell.2009.12.052 – ident: ref21 doi: 10.1016/0140-6736(91)90201-Y – ident: ref14 doi: 10.1007/s10654-010-9491-z – reference: 33317238 - Clin Mol Hepatol. 2021 Jan;27(1):87-90 |
| SSID | ssj0000702593 |
| Score | 2.5366657 |
| Snippet | Background/Aims: In this systematic review and meta-analysis, we aimed to clarify the effect of obesity on the occurrence of and mortality from primary liver... In this systematic review and meta-analysis, we aimed to clarify the effect of obesity on the occurrence of and mortality from primary liver cancer. This study... Background/AimsIn this systematic review and meta-analysis, we aimed to clarify the effect of obesity on the occurrence of and mortality from primary liver... In this systematic review and meta-analysis, we aimed to clarify the effect of obesity on the occurrence of and mortality from primary liver... Background/Aims In this systematic review and meta-analysis, we aimed to clarify the effect of obesity on the occurrence of and mortality from primary liver... |
| SourceID | nrf doaj pubmedcentral proquest pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 157 |
| SubjectTerms | Body mass index carcinoma, hepatocellular Liver cancer Mortality Obesity Original risk 내과학 |
| SummonAdditionalLinks | – databaseName: AUTh Library subscriptions: ProQuest Central dbid: BENPR link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7BFiEuvB-BggxCnEib2E6ccEEtagUSrCpe6s2yHbus2iYlu-X3M5N4tywCLpwiJY4U5xvPy-NvAJ5nobShIoZL76sU7bVNjWhMatA45JUPXg7Ho7--V9NpdXhYH8SE2zyWVS514qCom85RjnxboCVGeUFQX599T6lrFO2uxhYal2GDmMrkBDZ296YHH1dZFhRoPjLvcgwNUq54NRJtClFk2-6UtiN4toViWa4ZpoG_H81N24c_uZ6_V1D-YpL2b_zvZG7C9eiMsp1Rem7BJd_ehqsf4nb7HfgU2wYw0zYMPUVGheisC-xs5KhgJ1TVwRxJTv-K7bALXmg2nokZ3jz1C4Qlsp_chS_7e5_fvE1jF4bUoTO2SJWpHfdNESrfSJu7IG0tc2dyG7hSjhgDjXS5UoFjcCRNmYdaIcS25qUtfBD3YNJ2rX8ArDAYfRWyHOJKHoq6dC4LdeFr72Uo8gReLiHQLlKUU6eME42hCiGmETFNiGlCLIEXq-Fx3n8buEt4rgYRpfZwo-uPdFyh2rnSmVJxKxwqtsbbhtLD0ma2CQG1XALPUBr0sZsN79P1qNPHvcbA452uibosqxLYXAKuozKY6wu0E3i6eozLmPZmTOu787nmssT_okQtE7g_ytbqc4VAv0oIkYBak7q1-aw_aWffBqpwYkNEF-_hvz_rEVzjVKozZJY2YbLoz_1juOJ-LGbz_klcUz8BojQpww priority: 102 providerName: ProQuest |
| Title | Obesity and the risk of primary liver cancer: A systematic review and meta-analysis |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/33238333 https://www.proquest.com/docview/3125531200 https://www.proquest.com/docview/2464607394 https://pubmed.ncbi.nlm.nih.gov/PMC7820201 https://doaj.org/article/cc6ca672b3c040debde3184b0bdff880 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002663116 |
| Volume | 27 |
| WOSCitedRecordID | wos000605666500019&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | Clinical and Molecular Hepatology, 2021, 27(1), , pp.157-174 |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2287-285X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000702593 issn: 2287-2728 databaseCode: DOA dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVPQU databaseName: ProQuest Central (subscription) customDbUrl: eissn: 2287-285X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000702593 issn: 2287-2728 databaseCode: BENPR dateStart: 20110301 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Health & Medical Collection customDbUrl: eissn: 2287-285X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000702593 issn: 2287-2728 databaseCode: 7X7 dateStart: 20110301 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 2287-285X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000702593 issn: 2287-2728 databaseCode: PIMPY dateStart: 20110301 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB5BQagXxLMNlJVBiBOhie3ECbcWtaISXa14aTlZtmPDqm0WZbf8fmacdNlFIC5cEiVxJOeb8TzsyWeA51kobaiI4dL7KkV_bVMjGpMadA555YOX8ffoz-_UeFxNp_Vkbasvqgnr6YF74PadK50pFbfCob413jY0aydtZpsQUPnI-mLUs5ZMRRus0JdHxl2OKUHKFa96gk0himzfXdAyBM9eoTqWGw4p8vajm2m78KeQ8_fKyTVXdHwHbg8xJDvo-34Xrvn2Htw6HVbJ78OHge2fmbZhGOAxqh9n88C-99QS7JyKMZgjgXev2QH7RefM-l9Z4psXfoloDqQlD-DT8dHHN2_TYfOE1GEMtUyVqR33TREq30ibuyBtLXNnchu4Uo6I_ox0uVKBY04jTZmHWqFkbM1LW_ggHsJWO2_9LrDCYNJUyDKmgzwUdelcFurC197LUOQJvLxCULuBWZw2uDjXmGEQ4BoB1wS4JsATeLFqPnz33xoekjhWjYgJO95A_dCDfuh_6UcCz1CY-szN4vt0_jrXZ53GfOFE18Q4llUJ7F3JWg9jeKEFxn5oodCMJPB09RhHHy2pmNbPLxeayxJxUaKWCez0qrHqrhAYDgkhElAbSrPxPZtP2tm3yPBNJIYYmT36HwA8hm1OdThx2mgPtpbdpX8CN92P5WzRjeC6mqp4rEZw4_BoPHk_ikMJryYnp5MvPwEV9iEs |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1bb9MwFD4aHQJeuF8CAwwCnghLbCdOkBAal2nV2qoSA40nYzv2qLYlI-1A_Cl-I8dJ2lEEvO2Bp0iJE9nxd2728XcAHkUu1S7zDJfWZiHaax0qVqhQoXGIM-ssb45HfxiI0Sjb3c3HK_BjfhbGp1XOdWKjqIvK-DXydYaWGPGCk_ry6Evoq0b53dV5CY0WFtv2-zcM2aYv-m9wfh9Tuvl25_VW2FUVCA06F7NQqNxQWyQuswXXsXFc5zw2KtaOCmE8A57iJhbCUXT2uUpjlwvsss5pqhPrGH73DKxyBHvWg9Vxfzj-uFjVQQGiLdMvxVAkpIJmLbEnY0m0bg799geNnqEYpEuGsKkXgOatrN2fXN3fMzZ_MYGbl_63n3cZLnbONtlopeMKrNjyKpwbdukE1-BdVxaBqLIg6AkTn2hPKkeOWg4OcuCzVojxklE_JxvkhPeatGd-mjcP7Qxh17G7XIf3pzKkG9Arq9LeApIojC4TnjZxM3VJnhoTuTyxubXcJXEAT-dTLk1Hwe4rgRxIDMU8QiQiRHqESI-QAJ4smnfj_lvDVx4_i0aeMry5UdV7stNA0pjUqFRQzQwq7sLqwi9_cx3pwjnU4gE8RPTJfTNp3vfXvUru1xIDq77MPTVblAWwNgeY7JTdVJ6gK4AHi8eopvzekyptdTyVlKf4XwTLeQA3WywvussY-o2MsQDEEsqXxrP8pJx8bqjQPdsjurC3_92t-3B-a2c4kIP-aPsOXKA-LalZRVuD3qw-tnfhrPk6m0zre508E_h02lLwExE1h9A |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Obesity+and+the+risk+of+primary+liver+cancer%3A+A+systematic+review+and+meta-analysis&rft.jtitle=Clinical+and+molecular+hepatology&rft.au=Sohn%2C+Won&rft.au=Lee%2C+Hyun+Woong&rft.au=Lee%2C+Sangheun&rft.au=Lim%2C+Jin+Hong&rft.date=2021-01-01&rft.issn=2287-2728&rft.eissn=2287-285X&rft.volume=27&rft.issue=1&rft.spage=157&rft.epage=174&rft_id=info:doi/10.3350%2Fcmh.2020.0176&rft.externalDBID=n%2Fa&rft.externalDocID=10_3350_cmh_2020_0176 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2287-2728&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2287-2728&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2287-2728&client=summon |